You're reading the free version. Trader adds the live tape and alerts.
Start tracking
NAMS Sale Disclosure
Smither John W · SEC Form 4 · Filed Sep 9, 2026
Sale
Calculated transaction value
$40.51K
Smither John W Director
NAMS
Transaction date
Sep 4, 2026
Public filing date
Sep 9, 2026
Filing lag
Filed 5 days later
NAMS daily price context
Close on/before transaction
$25.4
Sep 4, 2026
First close after public filing
$21.86
Sep 10, 2026
30-day return after filing
-1.3%
Through Oct 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 1,600 shares @ $25.32
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-386508
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$40.51K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Newamsterdam Pharma Co N.v. NAMS Current | Sale | Sep 4, 2026 | $40.51K |